Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation that is in Phase Ia/Ib clinical trial in patients with solid tumors. The company''s pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma and solid tumors; CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas; and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. The company was incorporated in 2000 and is headquartered in Lexington, Massachusetts.

CRIS price history

interval date selector

agregation type selector

Date

Change

Chg%

Open

Min.

Max.

2022-09-30

1.6777

-0.1099

-6.15

1.7876

1.6677

1.8375

2022-09-30

1.7876

-0.0099

-0.55

1.7975

1.7576

1.8675

2022-09-30

1.7875

0.0000

0.00

1.7875

1.7676

1.9074

2022-09-30

1.7676

-0.0200

-1.12

1.7876

1.7276

1.7976

2022-09-30

1.7576

0.0500

2.93

1.7076

1.7576

2022-09-30

1.6777

-0.0100

-0.59

1.6877

1.6677

1.7476

2022-09-30

1.6577

-0.0400

-2.36

1.6977

1.6178

1.7276

2022-09-30

1.6277

-0.0999

-5.78

1.7276

1.6277

1.8874

2022-09-30

1.6977

0.0300

1.80

1.6677

1.6477

1.7077

2022-09-30

1.6178

-0.0299

-1.81

1.6477

1.6178

1.6477

2022-09-30

1.6377

-0.0200

-1.21

1.6577

1.6277

1.6577

2022-09-30

1.6677

0.0799

5.03

1.5878

1.6677

2022-09-30

1.6078

-0.0200

-1.23

1.6278

1.6078

1.6378

2022-09-30

1.6477

0.0200

1.23

1.6277

1.6078

1.6677

Trade Curis, Inc. - CRIS stock price

The Power Of Leverage

CRIS price history